Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry).
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry).
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry). Am J Cardiol. 2018 11 15; 122(10):1638-1646.
View in:
PubMed
subject areas
Atherosclerosis
Atherosclerosis
Coronary Artery Disease
Coronary Artery Disease
Drug Therapy, Combination
Drug Therapy, Combination
Drug-Eluting Stents
Drug-Eluting Stents
Female
Female
Follow-Up Studies
Follow-Up Studies
Humans
Humans
Incidence
Incidence
Male
Male
Middle Aged
Middle Aged
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Prospective Studies
Prospective Studies
Registries
Registries
Risk Assessment
Risk Assessment
Risk Factors
Risk Factors
Thrombosis
Thrombosis
Treatment Outcome
Treatment Outcome
United States
United States
Withholding Treatment
Withholding Treatment
authors with profiles
Usman Baber